Focused Alpha’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Focused Alpha's TAK Position: Q3 2026 in Review
Focused Alpha increased its Takeda Pharmaceutical (TAK) stake by 3% in Q3 2026, buying an estimated $10K and bringing the position to 19,460 shares worth $354K. The position accounts for 0.09% of the portfolio, ranked #198.
Focused Alpha first reported a position in TAK in Q4 2025 and has held it in 4 quarters since. 332 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Focused Alpha held 19,460 shares of Takeda Pharmaceutical worth $354K as of Q3 2026.
- Focused Alpha bought 563 Takeda Pharmaceutical shares in Q3 2026, an estimated $10K.
- Takeda Pharmaceutical made up 0.09% of Focused Alpha's portfolio in Q3 2026, its #198 holding.
- Focused Alpha first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
- 332 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.